GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Arena Pharmaceuticals, Inc. (ARNA) [hlAlert]

Rating:
Outperform
ARNA
down 29.33 %

Arena Pharmaceuticals, Inc. (ARNA) rated Outperform with price target $11 by Oppenheimer

Posted on: Monday,  Dec 1, 2008  9:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) on 12/01/2008, when the stock price was $3.75. Since
then, Arena Pharmaceuticals, Inc. has lost 29.33% as of 10/08/2015's recent price of $2.65.
If you would have followed this Oppenheimer's recommendation on ARNA, you would have lost 29.33% of your investment in 2502 days.

Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena's most advanced product candidate, lorcaserin, is being investigated in a Phase three clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/1/2008 9:25 AM Buy
None
3.75 11.00
as of 12/24/2008
1 Week down  -4.65 %
1 Month down  -41.00 %
3 Months   
1 YTD down  -41.00 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy